Company Filing History:
Years Active: 2019-2024
Title: Innovator Spotlight: Steven W. Paugh
Introduction
Steven W. Paugh, an esteemed inventor based in Memphis, TN, has contributed significantly to the field of cancer research through his innovative methods targeting glucocorticoid resistance in cancer therapies. With a total of two patents to his name, Paugh is at the forefront of developing transformative approaches in this critical area of medicine.
Latest Patents
Paugh's latest patents focus on “Methods for Overcoming Glucocorticoid Resistance and for Determining Glucocorticoid Resistance Potential in Cancer.” This invention provides groundbreaking methods to overcome glucocorticoid resistance in cancers by inhibiting the CASP1 enzyme. Additionally, it outlines diagnostic methods to assess glucocorticoid resistance potential by measuring the expression level or promoter methylation status of the CASP1 gene and/or the NLRP3 gene. These advancements hold promise for improving treatment efficacy in cancer patients who face challenges due to glucocorticoid resistance.
Career Highlights
Steven W. Paugh works at St. Jude Children's Research Hospital, where he leverages his expertise to advance pediatric cancer research. His dedication to improving cancer treatments reflects his commitment to making a difference in patients’ lives. His work not only enhances therapeutic approaches but also opens new avenues for diagnostic capabilities in cancer treatment.
Collaborations
Throughout his career, Paugh has collaborated with notable peers, including William Edward Evans and Erik Bonten. These collaborations have further enriched his research and have facilitated shared knowledge that contributes to the success of their projects in cancer research.
Conclusion
Steven W. Paugh's contributions to combating glucocorticoid resistance in cancer demonstrate his significant role as an innovator in medical research. His ongoing work at St. Jude Children's Research Hospital showcases his commitment to developing effective treatments, potentially transforming outcomes for cancer patients. With his patents paving the way for future discoveries, Paugh exemplifies the impact of dedicated researchers in the ongoing battle against cancer.